Medication Details
- Brand
- Cymra Life Sciences
- Designation
- Cybis T10:C25
- THC Potential Range (10% Legal Variance)
- 10mg
- CBD Potential Range (10% Legal Variance)
- 25mg
- Cultivated or Packaged in
- Australia
Stock Availability
We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.
Best Known Status: Unavailable
Main Importer/Distributor (Authoritative Stock)
- We're currently unsure who distributes this brand, some brands import directly and supply all pharmacies as required.
Dispensing Pharmacies
- We're currently unsure where to source this brand.
About Cymra Life Sciences Ltd.
Cymra Life Sciences is an Australian owned licenced and permitted cultivator and manufacturer of medical cannabis from the Australian Office of Drug Control.
We've set out to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.
We are focused on the development of cannabis medicines for chronic and neuropathic pain.
WHY? We don’t believe there is good long term medication options for chronic pain conditions (i.e opiates) are a good long term medication and have serious side effects.
We’re one of the first Australian companies to develop medical cannabis through tissue culture propagation, a method which delivers a consistent, natural product, free from pests and chemical dependencies. The team at Cymra Life Sciences is innovative, ambitious and fast-moving, all backed up by years of experience across pain management, medical research, plant genetics and breeding.
Patient Reviews
Coming soon, this feature is currently under active development.
Canada and many 
American states. Agree? Sign the 
Further National Health-Service Information on 